Indapamide Lp Krka (Indapamide)

Indapamide blocks the sodium‑chloride transporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urine output. The loss of fluid lowers blood volume and peripheral vascular resistance, which together lower blood pressure and diminish edema.

The exact dose of Indapamide Lp Krka is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and renal function. Healthcare professionals adjust the regimen to achieve optimal blood‑pressure control or edema reduction while monitoring safety.

Safety data for indapamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower risk of metabolic disturbances compared with classic thiazides. It is often preferred when clinicians need effective blood‑pressure control combined with modest diuretic effect, whereas loop diuretics are chosen for more severe fluid overload.

Indapamide Lp Krka tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain potency throughout its shelf life.

The medication is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether it should be taken in the morning to reduce nocturnal diuresis.

Serious risks include severe dehydration, acute kidney injury, marked electrolyte disturbances such as hyponatremia or hypokalemia, and profound hypotension. Patients should be educated to report symptoms like dizziness, fainting, rapid weight loss, or muscle weakness promptly.

Indapamide is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide diuretics, severe renal or hepatic impairment, and in those with anuria. Caution is also advised for individuals with uncontrolled diabetes, gout, or electrolyte disorders.